Condition: Clostridioides Difficile Infection · Sponsor: Lumen Bioscience, Inc.
This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in participants recently diagnosed with CDI who are scheduled to receive or are receiving SOC antibiotic therapy against C. difficile.
This description comes directly from the study's public registry record.
Carl Mason · 12068991904 · trials@lumen.bio
Asa Davis · 12068991904 · trials@lumen.bio
Always discuss trial participation with your own doctor first.
| Kaiser Permanente | Escondido, California, United States | Recruiting |
| Bridgeport Hospital | Bridgeport, Connecticut, United States | Recruiting |
| Gastroenterology Center of Connecticut | Hamden, Connecticut, United States | Recruiting |
| GI PROS Research | Naples, Florida, United States | Recruiting |
| Metro Infectious Disease Consultants - Atlanta | Decatur, Georgia, United States | Recruiting |
| Snake River Research | Idaho Falls, Idaho, United States | Recruiting |
| Metro Infectious Disease Consultants, LLC | Burr Ridge, Illinois, United States | Recruiting |
| DM Clinical Research | Oak Lawn, Illinois, United States | Recruiting |
| Baptist Health Research | Lexington, Kentucky, United States | Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| Mercury Street Medical | Butte, Montana, United States | Recruiting |
| Quality Clinical Research, Inc | Omaha, Nebraska, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05330182